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Abstract
Background: Alternative splicing is a widespread mechanism of gene expression regulation. Previous
analyses based on conventional RT-PCR reported the presence of an unspliced c-fos transcript in several
mammalian systems. Compared to the well-defined knowledge on the alternative splicing of fosB, the
physiological relevance of the unspliced c-fos transcript in regulating c-fos expression remains largely
unknown. This work aimed to investigate the functional significance of the alternative splicing c-fos pre-
mRNA.
Results: A set of primers was designed to demonstrate that, whereas introns 1 and 2 are regularly spliced
from primary c-fos transcript, intron 3 remains unspliced in part of total transcript molecules. Here, the
two species are referred to as c-fos-2 (+ intron 3) and spliced c-fos (- intron 3) transcripts. Then, we used
a quantitatively rigorous approach based on real-time PCR to provide, for the first time, the actual steady-
state copy numbers of the two c-fos transcripts. We tested how the mouse-organ context and mouse-
gestational age, the synthesis and turnover rates of the investigated transcripts, and the serum stimulation
of quiescent cells modulate their absolute-expression profiles. Intron 3 generates an in-frame premature
termination codon that predicts the synthesis of a truncated c-Fos protein. This prediction was evaluated
by immunoaffinity chromatography purification of c-Fos proteins.
Conclusion: We demonstrate that: (i) The c-fos-2 transcript is ubiquitously synthesized either in vivo or
in vitro, in amounts that are higher or similar to those of mRNAs coding for other Fos family members, like
FosB, ∆FosB, Fra-1 or Fra-2. (ii) Intron 3 confers to c-fos-2 an outstanding destabilizing effect of about 6-
fold. (iii) Major determinant of c-fos-2 steady-state levels in cultured cells is its remarkably high rate of
synthesis. (iv) Rapid changes in the synthesis and/or degradation rates of both c-fos transcripts in serum-
stimulated cells give rise to rapid and transient changes in their relative proportions. Taken as a whole,
these findings suggest a co-ordinated fine-tune of the two c-fos transcript species, supporting the notion
that the alternative processing of the precursor mRNA might be physiologically relevant. Moreover, we
detected a c-Fos immunoreactive species corresponding in mobility to the predicted truncated variant.
Published: 21 September 2007
BMC Molecular Biology 2007, 8:83 doi:10.1186/1471-2199-8-83
Received: 11 December 2006
Accepted: 21 September 2007
This article is available from: http://www.biomedcentral.com/1471-2199/8/83
© 2007 Jurado et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Molecular Biology 2007, 8:83 http://www.biomedcentral.com/1471-2199/8/83
Page 2 of 14
(page number not for citation purposes)
Background
Activator protein-1 (AP-1) is a dimeric transcription factor
regulating major physiological processes such as cell pro-
liferation, differentiation, neoplastic transformation,
apoptosis, and response to stress [1]. Main AP-1 compo-
nents in mammals are members of the Fos and Jun pro-
tein families. The Fos family includes the products of the
c-fos (the cellular counterpart of oncogene v-fos), fosB, fra-
1 and fra-2 genes. Fos proteins associate with Jun, but also
with other basic leucine-zipper (bZIP) proteins to create a
variety of AP-1 complexes [2].
The expression of c-fos is subjected to a tight regulation at
multiple levels. The c-fos gene undergoes rapid and tran-
sient transcriptional activation in response to a variety of
extracellular stimuli [3]. Both c-fos  mRNA and protein
turn over with short half-lives [4,5]. Additionally, when
the c-Fos protein is over-synthesized, the c-fos gene is tran-
scriptionally repressed [6].
Alternative splicing is a widespread mechanism of gene
expression regulation. The typical form of this regulation
results from tissue- or temporal-specific splicing events
that lead to the synthesis of either productive (protein-
coding) or non-productive (no protein- coding) RNAs.
Regarding transcription factors, alternative splicing prefer-
entially adds or deletes domains that are important for
their architectures and functions ([7] and references
herein). The production of multiple isoforms is a com-
mon strategy for regulating the activity of genes within the
Fos family (e.g. [8]). A particularly instructive example is
the differential splicing of the fosB transcript, which gen-
erates two mRNAs that encode proteins with antagonistic
activities. Briefly, alternative splicing removes codons
238–284 and causes a shift in the reading frame that
places a stop codon following the bZIP region. The trun-
cated protein (referred to as ∆FosB), missing the C-termi-
nal 101 aa of FosB, functions as a trans-negative regulator
of transcriptional activation and transformation, presum-
ably by competing with the full-length Fos protein in the
dimerization with Jun and binding to DNA steps [9-11].
Previous analyses [12,13] based on RT of total RNA fol-
lowed by conventional PCR have reported the presence of
a transcript isoform (hereinafter referred to as c-fos-2) in
several mammalian systems: (i) rat brain following kainic
acid treatment, (ii) primary cortical culture of mouse
brain treated with lipopolysaccharide, (iii) cartilage from
newborn mouse, and (iv) mouse and human cultured
stromal cells. Compared to the well-defined knowledge
on the alternative splicing of fosB, the physiological rele-
vance of c-fos-2 transcript in regulating c-fos expression has
not been well addressed.
The work described herein aimed to gain further insights
into the functional significance of the alternative splicing
of c-fos. To this end, we first undertook a systematic and
meticulous quantitation of the real copy numbers of c-fos
transcript variants by means of a real-time PCR methodol-
ogy [14-17]. We tested how the organ context, gestational
age, synthesis and turnover rates, and serum stimulation
of quiescent cells modulate the absolute expression pro-
files of the investigated c-fos transcripts. The translation of
these transcripts predicts the synthesis of a truncated c-Fos
protein, in addition to the canonical full-length counter-
part. From cultured cells we partially purified a c-Fos
immunoreactive species corresponding in mobility to the
predicted truncated species.
Results
Alternative splicing variants of c-fos messenger
Differential pre-mRNA splicing is an important mode of
regulating the steady-state abundance of a specific mRNA.
Based on the known structure of c-fos gene (Fig. 1A), a set
of primers (Fig. 1B) was designed to investigate the occur-
rence of any splicing variant that might be derived from
the primary c-fos transcript. Gene fosB was included for
comparison. Primer pairs E1U-E2L and E2U-E3L (located
in exons 1 and 2 and in exons 2 and 3, respectively) gen-
erated single RT-PCR amplicons of expected sizes and
sequences after regular splicing of introns 1 and 2 (Fig.
1C). However, the primer pair E3U-E4L revealed the pres-
ence of two transcript populations: while the shorter
amplicon (141 nt) corresponded to the canonical spliced
form of c-fos  message, the larger amplicon (258 nt)
retained the 117 nt of intron 3. These data confirmed that
intron 3 is not always spliced from the primary c-fos tran-
script [12,13]. To quantitate this second transcript species,
an additional primer pair (E3U-I3L) was designed. As
expected, these primers gave a unique RT-PCR product of
the predicted size (120 nt) and sequence.
Steady-state molecules of c-fos transcripts in animal 
tissues and cultured cells
Here we used a quantitatively rigorous approach based on
RT and real-time PCR amplification [14-17] to provide
novel information on the actual steady-state copy num-
bers of the two c-fos transcripts. Quantitations were car-
ried out in adult mouse organs, whole mouse embryos at
different developmental stages, and murine cultured cells.
We found that both transcripts were ubiquitously
expressed and presented vast differences in abundance
depending on the sample (Fig. 2). In the adult organs
examined, the canonical spliced c-fos  mRNA displayed
high steady-state levels in brain (10 molecules/pg of total
RNA) followed by heart, lung, and ovary (average of 4
molecules/pg), as compared to spleen and testis (about
0.4 molecules/pg), and the rest of the organs (around 0.07BMC Molecular Biology 2007, 8:83 http://www.biomedcentral.com/1471-2199/8/83
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RT-PCR amplicons from c-fos and fosB transcripts Figure 1
RT-PCR amplicons from c-fos and fosB transcripts. A) Schematic drawing of c-fos and fosB gene structures. Exons (E) 
are boxed and shaded in grey. Introns (I) are indicated by lines between exons, except for the alternatively spliced sequences 
that are indicated by brick filled in boxes. The beginning and end of exons are indicated by the corresponding nucleotide posi-
tions (NCBI/GeneBank accession numbers: V00727 and AF093624 for c-fos and fosB, respectively). B) Names, sequences and 
5'-position of upper (U) and lower (L) primers. C) Agarose (1.5%) gel electrophoresis analysis of RT-PCR products generated 
by different primer pairs (identified at the top of each line). Total RNA from NIH 3T3 cells was used as template. Forty cycles 
of PCR were performed as detailed [16]. Genomic DNA was further amplified by the E1U-E2L primer pair to exclude the pos-
sibility that our PCR conditions were not optimal for the amplification of the longest theoretical fragment, i.e. the 933 nt ampli-
con that should be observed if intron 1 remained unspliced in the c-fos transcript population [see Additional file 7]. The 
molecular weight marker was a 100-nt ladder from Roche.
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E1U 5’-CCAGCATGGGCTCTCCTGTCAACACA 815
E2U 5’-CCACGGTGACAGCCATCTCCACCA 1641
E2L 5’-TCCGTAAGGATGGGGCGCTCTGGT 1747
E3L 5’-GGCTGCAGCCATCTTATTCCGTTCCC 2317
E3U 5’-CGGAATCGGAGGAGGGAGCTGACAGATA 2324
E4L 5’-TCGGTGGGCTGCCAAAATAAACTCCAGT 2581
I3L 5’-ATGCTCAAGGACCCTGCGCCCATAGT 2440
E4U 5’-CGGGCTGCAAGATCCCCTACGAAGA 23225
I4U 5’-GCCGAGGTGAGAGATTTGCCAGGGTC 23178
E5L 5’-GACCTCCGGGCAGGTGAGGACAAAC 22951
I4L 5’-AGCCGTCAGGTTGGGGGGTGC 23050
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molecules/pg). Notably, this quantitative tissue-expres-
sion profile is not in good agreement with qualitative RT-
PCR results in public database. For instance, qualitative
RT-PCR (accession ID, MGI:1204456) generated a strong
c-fos amplification band from either liver or lung RNA and
no detectable signal from kidney RNA. However, quanti-
tative data given here (Fig. 2) showed much lower expres-
sion levels in both liver and kidney (around 0.07
molecules/pg RNA) than in lung (5.7 molecules/pg RNA).
These discrepancies might be due, at least partly, to the
experimental uncertainties of the end-point RT-PCR
methodology.
The c-fos-2 variant was present in smaller amounts in all
8-tissue samples, where its presence accounted for differ-
ent percentages of the total transcript molecules, ranging
from more than 20% in lung and ovary to about 2% in
testis. Regarding whole embryos, an over 7-fold overex-
pression in both c-fos transcripts occurred as early as E7
(gastrulating embryos). Thereafter, their amounts
declined to approximately the average numbers of the
steady-state copies measured in adult tissues. Therefore,
the c-fos-2 species accounted for a constant 8–9% of the
total transcript molecules throughout mouse embryonic
development.
Elevated levels of the two c-fos transcripts were also quan-
titated in NIH 3T3 and Hepa1-6 confluent cells. Interest-
ingly, at least in these 2 cell lines, we observed both
products with an about equal yield. This finding differs
from a recent report in which confluent stromal cells
expressed only the c-fos-2 transcript [13]. With regard to
the absolute amounts of transcripts coding for the rest of
proteins within the Fos family (Table 1 and data not
shown), we found that the c-fos-2 variant was nearly as
abundant in lung, liver, and kidney and in NIH 3T3 cells
as the transcripts coding for Fra-1 and Fra-2. Compara-
tively, the transcript coding for FosB displayed a much
lower level.
Organ-, embryo-, and cell type-associated differences in basal amounts of c-fos transcripts Figure 2
Organ-, embryo-, and cell type-associated differences in basal amounts of c-fos transcripts. Data are the numbers 
of transcript molecules per pg of total RNA. Regarding cultured cells, error bars (SEM) indicate transcript level variability 
among 13 (NIH 3T3) or 8 (Hepa1-6) independent cultures. Total RNA (pool of ~200 BALB/c mice) from animal organs and 
whole embryos were from Clontech. No error bars are shown for quantitations of these commercial samples of total RNA. 
E17 embryos are in late gestation (total of about 19 days). The percentage of c-fos-2 in total transcript amount (c-fos-2 plus 
spliced c-fos) is indicated for each of the sample examined.
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Differential stability of the two c-fos transcripts
The intrinsic stability of any transcript is an important
component of the gene expression program. We first tried
to determine the half-life of each investigated c-fos tran-
script in a whole animal study. For this purpose, we
administered actinomycin D (AmD) to stop transcription
and then quantitated the number of transcript molecules
remaining at various times after the transcription shut-off.
Surprisingly, in contrast to previous results with other
murine mRNAs [15], the decay rates of the c-fos transcripts
could not be calculated in animals, since their hepatic,
pulmonary and renal levels increased (not decreased)
upon the intraperitoneal injection of AmD (Fig. 3). These
results indicate that c-fos (an early response gene) is up-
regulated in vivo by AmD under conditions in which the
transcription of other genes is blocked [15]. We have pre-
viously addressed this problem in Saccharomyces cerevisiae
[18], where the levels of mRNAs that are particularly
responsive to environmental changes are up-regulated by
current procedures for blocking transcription (i.e. RNA
polymerase inhibition by specific drugs or thermal inacti-
vation of a temperature-sensitive mutant). Since AmD
doses higher than 2 mg kg-1 body weight and incubation
times longer than 16 h could not be used without affect-
ing the apparent healthy aspect of mice, we next consid-
ered the possibility of quantifying the decay rates of the
investigated c-fos transcripts in the cell-cultured model.
In contrast to animals, in cultured cells the molecule
number of each c-fos transcript isoform decayed exponen-
tially in the presence of AmD and their half-lives were
readily calculated from the equation of each decay line
(Fig. 4A). The turnover of the two spliced forms of fosB
mRNA and those of various non proto-oncogene tran-
Time-courses of c-fos transcripts in mouse kidney, lung and  liver in response to AmD Figure 3
Time-courses of c-fos transcripts in mouse kidney, 
lung and liver in response to AmD. Male BALB/c mice 
(see legend of Table 1) were intraperitoneally injected with 2 
mg kg-1 body weight of AmD dissolved in phosphate-buffered 
saline. Animals injected with phosphate-buffered saline 
served as vehicle controls. Total RNA was extracted at the 
indicated times. Data are the means of c-fos (triangles) or c-
fos-2 (circles) molecules/pg of total RNA ± SEM (n = 3 mice). 
Data at 0 min represent the mean values ± SEM of 5 control 
mice. No time-related effect was noted in these vehicle con-
trols. Some error bars are not visible because of small stand-
ard errors. Statistical significance was evaluated using analysis 
of variance followed by post hoc multiple comparison accord-
ing to the Student-Newman-Keuls method. Significant differ-
ences relative to control animals are indicated by filled-in 
symbols. For each transcript, the maximal fold increment is 
given in parentheses.
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Table 1: Absolute steady-state levels of transcripts encoding proteins of the Fos family in mouse lung
mouse c-fos c-fos-2 fosB fra1 fra2
1 2.80 0.59 0.035 0.96 1.93
2 4.52 0.62 0.039 0.98 2.42
3 3.37 0.81 0.033 1.03 2.48
4 3.04 0.66 0.030 1.03 1.63
5 2.00 0.49 0.022 1.15 2.73
6 3.08 0.47 0.023 1.26 2.34
7 2.14 0.16 0.012 1.26 2.04
8 2.41 0.41 0.018 1.44 2.60
9 3.57 0.61 0.022 1.51 2.61
10 3.71 0.88 0.033 1.29 2.82
11 4.16 0.42 0.014 1.13 2.67
12 3.90 0.58 0.038 1.37 2.94
mean ± SEM 3.22 ± 0.23 0.56 ± 0.053 0.027 ± 0.003 1.20 ± 0.050 2.44 ± 0.11
Male BALB/c mice of 7 weeks of age were obtained from Charles River Laboratories (Spain). Following a 3-day acclimation period animals were 
individually killed by cervical dislocation. The lung was removed and immediately frozen in liquid nitrogen. Mice were handled according to the 
norms stipulated by the European Community. The investigation was performed after approval by the Ethical Committee of the University of 
Córdoba (Spain). Data are transcript molecules/pg of total RNA.BMC Molecular Biology 2007, 8:83 http://www.biomedcentral.com/1471-2199/8/83
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scripts were also determined for comparison (Fig. 4B). We
found that the two species of c-fos transcripts displayed
rather different half-lives in cultured cells: the c-fos-2
decayed with a half-life of less than 3 min, whereas the
half-life of the spliced c-fos messenger was over 15 min
(Fig. 4A). Moreover, the kinetics and magnitudes of the
quantitated decays suggested that c-fos-2 is not merely a
splicing intermediate in the production of the mature c-fos
transcript [see theoretical considerations in Additional file
1]. In contrast to c-fos, both fosB transcripts exhibited iden-
tical half-lives of about 4 min (Fig. 4B). Transcript turno-
ver rates in the order of minutes was a characteristic of
proto-oncogenes since other mRNA species such as those
encoding for heme oxygenase 1, thioredoxin 1, and super-
oxide dismutase 3 presented turnover rates in the order of
hours.
The steady-state abundance of any transcript depends on
the balance between two opposing factors, its rate of for-
mation and degradation. We show that though both c-fos
transcripts are similarly abundant in cultured cells, the c-
fos-2 turned over about 6-fold faster than the spliced c-fos
mRNA. Both findings can only be conciliated if, at the
same time, the c-fos-2 isoform is produced at a higher rate.
Having determined the numbers of transcript copies and
the transcript half-lives, we can estimate their synthesis
rates. The result of such a calculation (Fig. 4B) suggests
that the major determinant of c-fos-2 transcript level in
cultured cells is its high rate of synthesis, as compared to
that of the spliced c-fos variant, and particularly to those
of both fosB and of non proto-oncogenes mRNAs.
Next, we asked ourselves whether cycloheximide (Cx), a
protein synthesis inhibitor, leads to the stabilization of
the alternative c-fos-2 transcript. We found (Fig. 5), that
the fast decay rate of the c-fos-2 species is not coupled to
Rates of transcript decay and synthesis in cultured cells Figure 4
Rates of transcript decay and synthesis in cultured 
cells. A) Decay rates of the c-fos-2 (open symbols) and c-fos 
(solid symbols) transcripts in NIH 3T3 (circles) and Hepa1-6 
(triangles) cells. Data are the percentages of transcript mole-
cules remaining after the addition of AmD. The half-life (t1/2) 
values calculated from the resulting decay lines are given for 
comparisons. B) Rates of transcript decay and synthesis in 
NIH 3T3 cells. Transcript synthesis rates (in molecules/min) 
were calculated from the basal amounts of transcript mole-
cules (per pg of total RNA) and their estimated half-lives (in 
minutes). These calculations are based on the assumption 
that though mRNA degradation is a complex process, it fol-
lows first-order kinetics[36]. The steady-state levels and 
rates of decay and synthesis of transcripts coding for both 
types of FosB protein (fosB and ∆fosB) and for heme oxygen-
ase 1 (ho1), thioredoxin 1 (trx1) and superoxide dismutase 3 
(sod3) are included for comparison.
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Changes in transcript decay upon translation inhibition Figure 5
Changes in transcript decay upon translation inhibi-
tion. Decay rates of c-fos-2 (circles) and c-fos (triangles) 
transcripts were determined as in Fig. 4, excepting that half 
of the plates were pretreated for 15 min with Cx (10 µg/ml). 
Then, AmD was added to all the plates and transcript decay 
was followed in the presence (solid symbols) and absence 
(open symbols) of Cx.
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translation, since it went on being ≤ 3 minutes in the pres-
ence of Cx, irrespective of the cell type (NIH 3T3 or
Hepa1-6). In contrast, as expected [5], the inhibition of
the translation transformed the spliced c-fos mRNA into a
stable species (at least in the 120 min period examined).
Transcript levels upon serum stimulation
Previous studies have shown that the stimulation of qui-
escent cells with 15% CS causes a rapid transient increase
in c-fos mRNA [19]. To gain more insight into the mecha-
nisms that might be influencing the cellular level of the
alternative c-fos-2 transcript, we decided to analyse
whether its accumulation mode after serum induction was
identical or not to that of the canonical spliced mRNA.
We found (Fig. 6) that CS induced different expression
profiles for both the spliced c-fos and the c-fos-2 transcript
variant. In both cases, a dramatic 11-fold increase (from
about 2.3 to 25 molecules/pg) was quantitated as soon as
5 min after serum addition. However, following this early
up-regulation, while the c-fos-2 copy number remained
relatively constant within 5–30 min, the amount of the
spliced c-fos mRNA increased until a maximum of 100-
fold was reached 30 min past stimulation. Thereafter,
both transcript levels decayed with different kinetics:
spliced c-fos mRNA molecules decreased to 50% of maxi-
mum in 20 min, while c-fos-2 lasted 37 min. Overall, these
distinguishing features caused rapid changes in the rela-
tive abundance of both transcripts throughout the period
analyzed in this experiment. Comparatively, our quantita-
tive PCR analysis revealed a much less differential expres-
sion of both fosB mRNA isoforms. Moreover, in contrast
to previous observations [11], the expression of fosB did
not precede that of ∆fosB mRNA at any time following
serum stimulation. In fact, both transcripts were induced
in a close parallelism throughout the first 30 min of serum
treatment, and, additionally, the ∆fosB  mRNA increase
persisted longer (Fig. 6).
Rapid changes in the rate of synthesis and/or the rate of
degradation of either the canonical c-fos mRNA or the c-
fos-2 variant, or both, would give rise to rapid changes in
the relative magnitudes of these transcripts. We examined
this possibility by calculating the formation and degrada-
tion rates of both transcripts in quiescent and serum-stim-
ulated cells. As shown in Table 2, the half-life of the c-fos-
2 variant remained essentially identical to that seen for
this transcript in confluent cells. Therefore, serum-related
changes in the copy number of the c-fos-2 transcript were
entirely explained by differences in its rate of synthesis.
Nonetheless, two trends could be envisaged regarding the
spliced c-fos mRNA: while an outstanding induction of its
synthesis would be the only determinant for the large up-
regulation of spliced c-fos mRNA within the first 30 min-
utes after serum addition, the subsequent rapid return of
this transcript to the prestimulation levels would require
an accelerated turnover rate (see Fig. 6).
Translation of c-fos-2 transcript
Intron 3 generates in c-fos-2 transcript an in-frame transla-
tion premature termination codon (PTC), thereby predict-
ing (if translated) the synthesis of a C-terminally
truncated protein 169 aa long. In an attempt to obtain
experimental proof of the synthesis of the predicted trun-
Table 2: Rates of synthesis and degradation of c-fos and c-fos-2 transcripts upon serum stimulation
c-fos c-fos-2
NIH 3T3 cells amount (molec/pg) half-life (min) synthesis (molec/min) amount (molec/pg) half-life (min) synthesis (molec/min)
confluent 12.1 17.9 0.47 12.8 2.6 3.41
quiescent 2.6 17.5 0.10 2.2 2.3 0.66
serum (15 min) 116.1 17.1 4.71 28.1 2.3 8.47
serum (60 min) 77.1 8.5 6.29 10.2 2.7 2.62
Experimental conditions are as in Figs. 4 and 6. Confluent cell data are those in Fig. 4.
Time-course of c-fos (left) and fosB (right) transcript levels in  serum-stimulated NIH 3T3 cells Figure 6
Time-course of c-fos (left) and fosB (right) transcript 
levels in serum-stimulated NIH 3T3 cells. Data are the 
means of transcript molecules per pg of total RNA ± SEM 
from independent cultures. Some error bars are not visible 
because of small SEM.
m
R
N
A
 
m
o
l
e
c
u
l
e
s
 
/
 
p
g
 
t
o
t
a
l
 
R
N
A
Time (min)
300
150
0
90 60 0
c-fos
c-fos-2
40
20
0
fosB
∆ ∆ ∆ ∆fosB
120 90 60 0 120 30 30BMC Molecular Biology 2007, 8:83 http://www.biomedcentral.com/1471-2199/8/83
Page 8 of 14
(page number not for citation purposes)
cated c-Fos protein, we first investigated whether the c-fos-
2 transcript was present in the cellular cytoplasm. To this
end, RNA was isolated from separate cytoplasmic and
nuclear fractions of NIH 3T3 cells, and then the resulting
RNAs were analyzed by end-point RT-PCR. As shown in
Fig. 7, the c-fos-2 transcript was present in both cellular
fractions, like the unspliced fosB transcript. In contrast, no
unspliced gpx1 pre-mRNA was present in the cytoplasmic
fraction showing an efficient cellular fractionation.
Given the presence of the c-fos-2 transcript in the cyto-
plasm, we next evaluated whether the truncated c-Fos var-
iant accumulated in serum-stimulated cells. For this
purpose, c-Fos proteins were partially purified by immu-
noaffinity chromatography from NIH 3T3 cell extract fol-
lowing 30 min serum stimulation. Immunoblot analysis
with anti-cFos Ab of the eluate column revealed several
electrophoretically distinguishable bands (Fig. 8B). The
higher molecular weight bands matched the multiple
forms of the full-length c-Fos protein that appeared in the
range of 53- to 68-kDa [4,20]. Bands detected in the range
of 42- to 50-kDa might be c-Fos breakdown products.
Finally, the discrete immunoreactive species correspond-
ing in mobility to a ~23-kDa protein would be the trun-
cated c-Fos form. This band was not detected in crude
extract from either serum-starved or serum-stimulated
cells. The possibility that the ~23-kDa band would be pri-
mary Ab light chains leaching off the immunoaffinity col-
umn was excluded by using only the secondary Ab [see
Additional file 2]. Furthermore, the possibility that the
~23-kDa band would be a non-specific protein co-puri-
fied with the rabbit anti-cFos Ab was excluded by using a
different primary Ab in the Western blotting [see Addi-
tional file 3].
Discussion
c-Fos proto-oncoprotein is a key cell regulator, whose
improper expression is oncogenic, both in cultured cells
and living organisms. To avoid the deleterious effects of
deregulated expression, c-fos  is subjected to numerous
transcriptional and posttranscriptional controls [2]. Dif-
ferential pre-mRNA splicing is an important mode of reg-
ulating the activity of mammalian genes (e.g. [7]). Our
interest in c-fos splicing stems from previous studies on
fosB where a truncated spliced variant missing the C-ter-
minus of FosB appears to be of great physiological rele-
vance, e.g. in mediating long-term adaptive changes in the
nervous system [21].
Murine c-fos gene comprises 4 exons and 3 introns span-
ning ~3.4 kb of chromosome 12. By means of specific
primers, we first explored the presence of intron
sequences in the transcript population derived from c-fos.
We demonstrated that whereas introns 1 and 2 are regu-
larly spliced from the precursor RNA, intron 3 remains
unspliced in part of the total transcript molecules. Follow-
ing this finding, we performed a robust and sensitive RT-
PCR methodology for providing for the first time a com-
prehensive quantitation of the absolute expression levels
of each transcript isoform: the canonical spliced c-fos and
the alternative c-fos-2. Comparisons of expression levels
across 8 mouse organs, 3 fetal stages and 2 cultured cell
RT-PCR analysis of cytoplasmic and nuclear RNAs Figure 7
RT-PCR analysis of cytoplasmic and nuclear RNAs. 
Cytoplasmic (C) and nuclear (N) RNAs were isolated by 
using the PARIS™ Kit (Ambion) according to the manufac-
turer's protocol. RT-PCR conditions were as in Fig. 1. The 
RT-PCR product of 120 nt amplified by the E3U-I3L primer 
pair (see Fig. 1) indicates the presence of the c-fos-2 tran-
script in both cytoplasmic and nuclear fractions. Amplifica-
tion of the unspliced fosB transcript (I4U-I4L primers) was 
included for comparison. Transcript coding for glutathione 
peroxidase 1 was amplified as control of efficient cellular 
fractionation. Primer UGPX1 (5'-GCAGAAGCGTCT-
GGGACCTCGTG) was located in gpx1 exon 1, and primer 
LGPX1 (5'-GGGAATTCAGAATCTCTTCATTCT TGCCA) in 
gpx1 exon 2 (the intron between both exons is 218 nt long). 
UGPX1- LGPX1 primers generated a single RT-PCR product of 
101 nt when using the cytoplasmic RNA as template, indicat-
ing no detectable contamination with nuclear gpx1 pre-
mRNA. In contrast when using the nuclear RNA as template, 
a fragment 319 nt long was detected in addition to the 
expected product from spliced gpx1 mRNA. Since the 
Ambion's PARIS™ Kit is designed for the isolation of both 
RNA and protein from the same sample, efficient cellular 
fractionation was further confirmed by Western blot analysis 
(botton panel) with an Ab specific for the cytoplasmic glycer-
aldehyde-3-phosphate-dehydrogenase (GAPDH). GAPDH 
was present only in the cytoplasmic fraction, further indicat-
ing no detectable contamination with the nuclear fraction.
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lines led to four observations: (i) The c-fos-2 transcript is
ubiquitously synthesized either in vivo or in vitro situa-
tions. (ii) This isoform is present in amounts that are
higher or similar to those of mRNAs coding for other Fos
family members like FosB, ∆FosB, Fra-1 or Fra-2. (iii) The
c-fos-2 variant is frequently processed in certain mouse tis-
sues, like ovary and lung, and in confluent cell cultures,
where both transcript isoforms are produced in about
equal quantities. (iv) No obvious relationship exists
between total amount of c-fos transcripts and the relative
quantity of the c-fos-2 form. For instance, c-fos-2
accounted for about 9% of total transcript molecules in
liver and about 6% in brain, though this last organ
exceeds the hepatic steady-state amount by over 75-fold.
On the whole, these findings support the notion that the
c-fos-2 copy number might be controlled.
The number of copies of any transcript is determined by a
delicate balance between opposing synthesis and degrada-
tion mechanisms. Here we show that the presence of
intron 3 confers to the c-fos-2 transcript a destabilizing
effect of about 6-fold, e.g. reducing the transcript half-life
from 18 to 3 min in confluent NIH 3T3 cells (Fig. 4).
The canonical c-fos mRNA is targeted for decay by two
functionally independent instability determinants. One
of these determinants (designated mCRD) is located in
the protein-coding region and the other (an AU-rich ele-
ment) in the 3'-untranslated end of the c-fos mRNA [22].
The mRNA decay mediated by mCRD represents a "sui-
cide" mechanism in which translation of the mCRD-con-
taining RNA results in the rapid degradation of the
message [23]. Here we show that the half-lives of the c-fos
and c-fos-2 transcripts are affected differently by inhibi-
tion of the translation, since cycloheximide caused the sta-
bilization of only the canonical c-fos mRNA (Fig. 5). This
result suggests that the shorter half-life of the alternative c-
fos-2 species is independent of translationally coupled
mRNA turnover mechanisms, like the one directed by the
mCRD determinant. Accordingly, the c-fos-2 transcript
with the PTC lying in the last intron 3 (Fig. 8A) should be
also immune to the so-called nonsense-mediated decay
(NMD). It is noteworthy that this latter was anticipated
given that one critical determinant of whether a mamma-
lian transcript is subjected to NMD is the presence of a
splicing-generated exon-exon junction >50–55 nt down-
stream the PTC (recently reviewed in [24] and [25]). In
the absence of these two translationally coupled mRNA
turnover mechanisms, an intriguing question remains to
be answered: Why is the c-fos-2 transcript degraded at a
faster rate than the canonical c-fos message?.
A recent paper by Moraes et al [26] indicates that the CUG-
binding protein (CUG-BP) plays a role in c-fos  mRNA
decay. By means of an in vitro deadenylation assay, they
showed that CUG-BP binding to c-fos mRNA stimulates
the poly(A) shortening by the PARN deadenylase. Since
deadenylation is a rate-limiting step in the turnover of
most mRNAs, we hypothesized that the presence of intron
Detection of c-Fos immunoreactive species Figure 8
Detection of c-Fos immunoreactive species. A) Nucle-
otide sequence of c-fos intron 3 and flanking exons 3 and 4. 
Lower case letters refer to intronic nucleotides and upper 
case letters to exonic nucleotides. Minimal functional 
sequences within the mCRD are underlined. The encircled 
triplets encode the aa residues that contact to DNA. Triplets 
encoding two out of the five-leucine residues of the LZ motif 
are indicated in italics. The stop codon in intron 3 is boxed 
and shaded in grey. B) Western blot analysis of c-Fos pro-
teins purified by immunoaffinity chromatography. A crude 
extract from NIH 3T3 cells stimulated with serum for 30 min 
was loaded onto the immunoaffinity column. The column elu-
ate (E-30), as well as the input crude extract (CE-30) and the 
crude extract from serum-starved (CE-0) cells were sub-
jected to inmunoblot analysis as described under "Methods". 
The positions of molecular size standards are indicated on 
the left in kDa. GAPDH was used for loading control.
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3 in the c-fos-2 transcript might accelerate its decay by the
above-referred mechanism. We reasoned that in this case,
the proportion between both c-fos  transcript variants
might change when using an anchored oligo(dT)primer
(5'-T20VN-3'), rather than random primers, in the cDNA
synthesis. This approach allowed us to track specifically
the transcripts that retained poly(A)+ tails of a sufficient
length to allow priming. We found [see Additional file 4]
that the poly(A)+ population has practically the same copy
numbers of c-fos and c-fos-2 transcripts as the overall RNA
population. Moreover, the rate at which each transcript
disappeared from the poly(A)+ population was similar to
their overall decay rates [see Additional file 4]. These data
seem to favour the idea that the two transcripts undergo
deadenylation at the same rate, which seems to be in
agreement with the synchronous deadenylation pattern
seen for c-fos RNA both in vivo and in vitro [26,27]. Further
work should pursue the identification of new instability
determinants within the c-fos-2 transcript variant.
Shur et al [13] have recently reported rapid changes in c-
fos-2 and c-fos transcript levels in response of the osteob-
lastic cells to a challenge with dexamethasone (a pharma-
cological glucocorticoid hormone). Control of c-fos
splicing through the interaction of the glucocorticoid
receptor with the c-fos-2 transcript was the mechanism
proposed to explain the observed changes. Here we too
show that the proportion between both c-fos transcript
variants changes rapidly and transiently upon the stimu-
lation by serum of NIH 3T3 fibroblasts in quiescence. Our
data indicate that differential rates of synthesis determine
the large up-regulation of spliced c-fos relative to c-fos-2
level at the early stage of the serum response. However,
destabilization of the newly synthesized c-fos  message,
possibly as it is being translated, contributes to complet-
ing the response and restoring the ~50% yield (percentage
of total transcript molecules) quantitated in confluent cul-
tures. This temporal sequence of events further supports
the idea that the alternative processing of the primary c-fos
transcript might be of physiological relevance, given that
a relatively short extension of c-fos expression is sufficient
for fibroblasts to manifest properties of cell transforma-
tion [28].
Translation of the c-fos-2 transcript predicts the synthesis
of a truncated protein lacking 211 aa at the carboxyl-ter-
minus. We partially purified by immunoaffinity chroma-
tography a c-Fos protein (verified by Western blot) with
an apparent molecular weight of 23-kDa as judged by
SDS-polyacrylamide gel electrophoresis. This finding sug-
gests that the truncated variant of c-Fos is expressed in
NIH 3T3 cells. The truncation would occur after the con-
served basic domain for DNA binding but prior to the
adjacent leucine zipper for dimerization (Fig. 8). There-
fore, the truncated c-Fos should be inactive for transfor-
mation and transactivation since the functional integrity
of the bZIP motif is required for these activities [29].
Moreover, the truncated c-Fos (unable to heterodimerize)
should not exhibit antagonistic functional properties with
the canonical longer counterpart, as in the case of ∆fosB
[9-11]. On the other hand, however, the truncated c-Fos
species might gain in stability as predicted by the loss of
the main destabilizing activity residing at the C-terminal
region [30,31].
What might the biological significance of the above-
referred truncated variant of c-Fos protein be? One could
speculate with the idea that the truncated species is just
the side effect of the c-fos-2 translation occurring or toler-
ated in the cells. Nonetheless, a more active role in regu-
lating gene expression could also be envisaged, since the
truncated c-Fos would retain the DNA binding domain
(Fig. 8). Two pathways have been described for binding
dimeric proteins to DNA. In the dimer pathway, proteins
first form dimers and then go on to bind DNA. Along the
monomer pathway, a monomer•DNA complex is formed
first, followed by recruitment of the second monomer to
form the final complex. A growing number of dimeric
DNA-binding proteins are able to form complexes with
DNA via a monomer pathway. In fact, the monomer path-
way is considered the best option for a faster and more
specific formation of the final complex ([32] and refer-
ences herein). Although Fos and Jun monomer•DNA
complexes are difficult to observe, particularly in gel retar-
dation experiments (e.g. see [33]), recent stopped-flow
fluorescence studies on the kinetics of Fos•Jun•DNA
complex formation indicate that both protein monomers
bind DNA sequentially and assemble their dimerization
interface while interacting with DNA [32]. These data
allow us to speculate with the possibility [34] that even
low levels of the truncated c-Fos variant might influence
AP-1 mediated gene expression through the formation of
non-productive monomer•DNA intermediates at specific
DNA target sites. Additional experiments would be
required to support such a notion.
Conclusion
Here we provide the first absolute (molecule number)
quantitative analysis of alternative spliced transcript iso-
forms derived from the c-fos precursor RNA. We confirm
that intron 3 remains in the transcript population derived
from c-fos. We demonstrate that this transcript (here
referred as c-fos-2) is ubiquitously synthesized, either in
vivo (various mouse-tissues, gestational-ages) or in vitro
(different murine cell lines), in amounts that are higher or
similar to those of mRNAs coding for other Fos family
members. Changes in the synthesis and/or degradation
rates of both isoforms (the canonical spliced c-fos mRNA
and the c-fos-2 variant) indicate a co-ordinated fine-tune
of transcript molecules, supporting the notion that theBMC Molecular Biology 2007, 8:83 http://www.biomedcentral.com/1471-2199/8/83
Page 11 of 14
(page number not for citation purposes)
alternative processing of the c-fos precursor RNA might be
physiologically relevant. Moreover, translation of the c-
fos-2 transcript predicts the synthesis of a truncated c-Fos
protein. We detected a c-Fos immunoreactive species cor-
responding in mobility to the predicted truncated protein.
Methods
Cell culture and treatments
NIH 3T3 (ATCC: CRL-1658) and Hepa1-6 (ATCC: CRL-
1830) cells were cultured in Dulbecco's modified Eagle
medium (DMEM) supplemented with 10% calf serum
(CS) or foetal bovine serum, respectively. For mRNA
decay quantitation, cells were seeded into 75 cm2 flask at
a density of 3 × 106 cells/flask and cultivated for 48 h
before the addition of 10 µg/ml actinomycin D (AmD). At
different times thereafter, cells were scraped, washed once
with phosphate-buffered saline, and immediately frozen
in liquid nitrogen for total RNA purification. For serum
stimulation, NIH 3T3 cells were made quiescent by 48 h
incubation in DMEM with 0.5% CS. Cultures were then
stimulated by re-feeding quiescent cells with 15% CS.
Cells were incubated further and collected at different
times as for AmD treatment. Data presented are means of
at least two independent cell cultures.
Primer design
Primers directed against different regions of the c-fos and
fosB genes (Fig. 1A) were designed with the Oligo 6.1 soft-
ware (Molecular Biology Insights), as detailed in [35].
Primer positions (Fig. 1B) were chosen to detect intron
sequences in the transcript population derived from c-fos.
For comparison, primers for quantitation of the two well-
defined forms of fosB transcript were also designed [9-11].
To obtain high specificity and performance, primers were
required to have high Tm (≥82°C), optimal 3'-∆G (≥ - 3
kcal/mol) value, and to be hairpin and duplex free. All
primer pairs produced amplicons of the predicted size
(Fig. 1C). All PCR products were further verified by nucle-
otide sequencing (ABI 377 DNA sequencer).
RNA preparations and reverse transcription
Total RNA was extracted by using Tri-Reagent™ (Sigma)
according to the manufacturer's protocol. Contaminating
genomic DNA was removed by DNase I (Ambion). RNA
quality was checked electrophoretically and quantitation
was made spectrophotometrically. Lack of DNA contami-
nation was confirmed by PCR amplification of RNA sam-
ples without previous cDNA synthesis. The standard RNA
was synthesized in vitro from a laboratory-engineered
DNA fragment containing a T7 polymerase-binding site,
by means of a commercial RNA transcription kit (Strata-
gene). cDNA was generated from 2 µg of total RNA from
each sample, using the M-MLV reverse transcriptase (Life
Technologies) and random hexamers (Invitrogen).
Real-time PCR
Real-time PCR reactions were performed in quadruplicate
by using 50 ng of cDNA template, 0.3 µM of each primer
(Fig. 1), 3 mM MgCl2, 250 µM of each dNTP, 0.75 units of
Platinum Taq DNA polymerase, and 1:100000 SYBR
Green I dye (Roche) in a volume of 25 µl. Reactions were
analyzed on an iCycler iQ Real-Time PCR System (Bio-
Rad). Cycling conditions were as follows: 2 min at 95°C
for the Platinum Taq activation and 40 cycles for the melt-
ing (15 s, 95°C) and annealing/extension (30 s, 70°C)
steps. Replicate PCR reactions generated highly reproduc-
ible results with SEM <10% of the mean (<1% for thresh-
old cycle) [see Additional file 5]. No primer-dimers were
detected. Primers used for absolute quantitation of c-fos
and fosB transcripts showed optimal (~100%) PCR effi-
ciencies in the range of 20 to 2 × 105 pg of total RNA input
with high linearity (r > 0.99) [see Additional file 6]. An
absolute calibration curve was constructed with an exter-
nal standard in the range of 102 to 109 RNA molecules [see
Additional file 5]. The number of transcript molecules was
calculated from the linear regression of the standard
curve, as described previously [16] and exemplified in
Additional file 5. The amount of c-fos mRNA molecules
lacking intron 3 was estimated by subtracting the mole-
cules with intron 3 (determined with E3U-I3L) from the
total molecule number (determined with E3U-E4L). Sim-
ilarly, the amount of mRNA molecules coding for ∆FosB
was estimated by subtracting the molecules for the full-
length FosB (determined with I4U-I4L) from the total
molecule number (determined with E4U-E5L) (Fig. 1).
Immunoaffinity purification of c-Fos proteins
Rabbit polyclonal Ab (Calbiochem, PC05) against the N-
terminal region (aa 4–17) shared by the full-length and
the putative truncated c-Fos protein were coupled to cya-
nogen bromide (CNBr)-activated agarose (Sigma C9142)
following the manufacturer's recommendations. NIH 3T3
cells were cultured as described above. The accumulation
of c-Fos proteins was promoted by 30 min serum stimula-
tion. The cells were harvested and then lysed in 150 µl of
buffer A (50 mM Tris-HCl pH7.4, 150 mM NaCl, 0.03%
Tween 20, 0.4 mM Na3VO4, 0.4 mM EDTA, 10 mM NaF,
10 mM sodium pyrophosphate, 10 µg/ml aprotinin, 10
µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluo-
ride), by using a polypropylene pestle for microcentrifuge
tubes mounted in a cordless motor and 4 cycles of freez-
ing in liquid nitrogen and thawing at room temperature.
The cell lysate was centrifuged at 16000 × g for 10 min at
4°C. The resulting supernatant (crude extract) was
applied to the immunoaffinity column, which was then
washed extensively with buffer A. The bound proteins
were eluted with two volumes of 100 mM glycine-HCl
(pH 2.8). The eluate from the immunoaffinity column
was neutralized with NaOH for Western blot analysis as
described below.BMC Molecular Biology 2007, 8:83 http://www.biomedcentral.com/1471-2199/8/83
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Western blotting
Proteins were separated on 12% sodium dodecyl sulfate
(SDS)-polyacrylamide gel and transferred onto Hybond-P
PVDF membrane (Amersham Biosciences) by electroblot-
ting. Membranes were blocked with 2% non-fat milk
powder in TTBS (25 mM Tris-HCl pH 7.6, 150 mM NaCl,
0.03% Tween-20) for 4–5 h at room temperature and then
incubated overnight with 1:250 of primary Ab (Anti-c-
Fos, Calbiochem PC05) in blocking buffer at 4°C. After
washing the blots with blocking buffer, the membranes
were incubated with 1:4000 of a secondary anti-rabbit IgG
Ab (Sigma, A9169) to which horseradish peroxidase had
been covalently coupled. Blots were developed using the
ECL-Plus kit (Amersham Biosciences) following the man-
ufacturer's instructions. The membranes were stripped by
washing 30 min in stripping buffer (0.2 M glycine pH2.5,
0.1% SDS) at room temperature and reprobed with
1:2000 of anti-GAPDH Ab (Santa Cruz Biotechnology, sc-
25778) for control loading.
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Additional material
Additional file 1
Empirical and theoretical decay of c-fos transcript. Various theoretical 
decays were generated under the assumption that the c-fos-2 transcript is 
merely a splicing intermediate and therefore the molecule number of c-fos 
might increase on behalf of c-fos-2 in a time-dependent manner in the 
presence of the transcription inhibitor AmD. Theoretical data are com-
pared with experiment results shown in Fig. 4.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2199-8-83-S1.doc]
Additional file 2
Confirmation that the ~23-kDa band detected by Western blot is not the 
primary Ab light chain. The E-30 eluate was subjected to inmunoblot 
analysis as described in Fig. 8. The ~23-kDa band was not detected when 
using only the secondary Ab, excluding the possibility that this band might 
be anti-cFos Ab light chains leaching off the immunoaffinity column.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2199-8-83-S2.ppt]
Additional file 3
Confirmation that the ~23-kDa band detected by Western blot is not a 
non-specific protein co-purified with the rabbit anti-cFos Ab. c-Fos pro-
teins were partially purified by immunoaffinity chromatography as 
described under "Methods" for the experiment in Fig. 8. The exception 
was that the rabbit polyclonal anti-cFos Ab (Calbiochem, PC05) was cou-
pled to N-hydroxysuccinimide (NHS)-activated (instead of to CNBr-acti-
vated) Sepharose (Amersham Biosciences 28-903-28). Western blotting 
was as described under "Methods", except for the primary (mouse mono-
clonal anti-cFos; Calbiochem OP17) and secondary (anti-mouse IgG; 
Sigma A9917) Ab. The immunogen used to generate the mouse anti-cFos 
Ab was a synthetic peptide corresponding to aa residues 128–152 (trans-
lation of the c-fos-2 transcript predicts the synthesis of a truncated protein 
169 aa long). For other details see the Fig. 8 legend.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2199-8-83-S3.ppt]
Additional file 4
Comparison between poly(A)+ and overall RNA populations. Total RNAs 
from NIH 3T3 cells treated as in Fig. 4 were retrotranscribed with ran-
dom hexamers (see "RNA preparations and reverse transcription" subsec-
tion of "Methods") or anchored oligo(dT)primer (5'-T20VN-3') 
(Invitrogen). A) Overall (solid symbols) versus poly(A)+ (open symbols) 
decay rate of c-fos-2 (circles) and c-fos (triangles) transcripts, respec-
tively. B) Starting amounts (100% at time 0 min) of c-fos and c-fos-2 
transcripts.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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